β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells

Multidrug resistance (MDR) is a primary obstacle to curative cancer therapy. We have previously demonstrated that β-casein (β-CN) micelles (β-CM) can serve as nanovehicles for oral delivery and target-activated release of hydrophobic drugs in the stomach. Herein we introduce a novel nanosystem based...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar-Zeev, Maya, Assaraf, Yehuda G., Livney, Yoav D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029629/
https://www.ncbi.nlm.nih.gov/pubmed/26989076
http://dx.doi.org/10.18632/oncotarget.8019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029629/
https://www.ncbi.nlm.nih.gov/pubmed/26989076
http://dx.doi.org/10.18632/oncotarget.8019

Ejemplares similares